We are live on
!
Find out more
SAM
Sectoral Asset Management Portfolio holdings
AUM
$121M
1-Year Est. Return
73.47%
This Fund
S&P 500
This Quarter
Est. Return
+16.08%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$232M
AUM Growth
-$281M
(-55%)
Cap. Flow
-$304M
Cap. Flow
% of AUM
-130.94%
Top 10 Holdings %
Top 10 Hldgs %
35.11%
Holding
133
New
10
Increased
39
Reduced
47
Closed
29
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
argenx
ARGX
|
+$4.1M |
| 2 |
SLRN
ACELYRIN
SLRN
|
+$2.78M |
| 3 |
Merck
MRK
|
+$2.54M |
| 4 |
Edgewise Therapeutics
EWTX
|
+$2.3M |
| 5 |
Travere Therapeutics
TVTX
|
+$2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RCM
R1 RCM Inc. Common Stock
RCM
|
+$11.2M |
| 2 |
BPMC
Blueprint Medicines
BPMC
|
+$10.6M |
| 3 |
HealthEquity
HQY
|
+$10.5M |
| 4 |
Evolent Health
EVH
|
+$10.4M |
| 5 |
RadNet
RDNT
|
+$10.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 99.21% |
| 2 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Tenet Healthcare
THC
$20.4B
| – | – |
-91,500
| Closed | -$6.03M |
|
127
Veralto
VLTO
$23.4B
| – | – |
-3,658
| Closed | -$309K |
|
|
VTYX
128
DELISTED
Ventyx Biosciences
VTYX
| – | – |
-88,000
| Closed | -$3.06M |
|
|
NARI
129
DELISTED
Inari Medical, Inc. Common Stock
NARI
| – | – |
-138,043
| Closed | -$9.03M |
|
|
RCM
130
DELISTED
R1 RCM Inc. Common Stock
RCM
| – | – |
-744,194
| Closed | -$11.2M |
|
|
SWAV
131
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| – | – |
-17,400
| Closed | -$3.46M |
|
|
SGEN
132
DELISTED
Seagen Inc. Common Stock
SGEN
| – | – |
-9,210
| Closed | -$1.95M |
|
|
HZNP
133
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| – | – |
-2,515
| Closed | -$291K |
|
Similar funds
RIP
LFWA
CF
WIM
MW
AFC
TGM
BIS
Sectoral Asset Management's Q4 2023 Portfolio in Review
As of Q4 2023, Sectoral Asset Management held 133 positions worth $232M, down 55% from $514M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Sectoral Asset Management withdrew a net $304M in Q4 2023, closing 29 positions and reducing 47 holdings. Its most notable exit was R1 RCM Inc. Common Stock, an estimated $11.2M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 97% a quarter earlier, followed by Industrials.
Against the trend, Sectoral Asset Management opened a new position in ACELYRIN worth $2.43M.
- Sectoral Asset Management's largest Q4 2023 buy was ACELYRIN: 325,549 shares worth $2.43M.
- Sectoral Asset Management added most to argenx in Q4 2023, an estimated $4.1M increase.
- Sectoral Asset Management's biggest Q4 2023 reduction was Blueprint Medicines, cutting an estimated $10.6M.
- Sectoral Asset Management fully exited R1 RCM Inc. Common Stock in Q4 2023, selling an estimated $11.2M.
- Sectoral Asset Management's ten largest holdings make up 35% of its $232M portfolio in Q4 2023.
- Sectoral Asset Management opened 10 new positions and closed 29 in Q4 2023.
- Sectoral Asset Management's portfolio value fell 55% quarter-over-quarter to $232M.
Based on Sectoral Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.